跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERYSOL FOR ORAL SUSPENSION 200 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
ERYSOL FOR ORAL SUSPENSION 200 MG/5 ML
Approved
THERAPEUTIC
ERYSOL FOR ORAL SUSPENSION 200 MG/5 ML
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Mar 18, 1988
Approval ID
d4e24917dbdede73
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
d4e24917dbdede73
Drug Name
ERYSOL FOR ORAL SUSPENSION 200 MG/5 ML
Product Name
ERYSOL FOR ORAL SUSPENSION 200 MG/5 ML
Approval Number
SIN00126P
Approval Date
1988-03-18
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
GRANULE, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01FA01
Atc Item Name
erythromycin
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATE EQV ERYTHROMYCIN
200 mg/5 ml
ERYTHROMYCIN ETHYLSUCCINATE EQV ERYTHROMYCIN
200 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 18, 1988
Approval ID
d4e24917dbdede73
Type
Therapeutic
Back to HSA Approvals